Direct head-to-head trial data is still limited, so cross-trial comparisons should be made carefully
Following all protocols optimizes chances of achieving upper range results
[DOI] [PubMed] [Google Scholar] 4.Bezin J, Gouverneur A, Pnichon M, Mathieu C, Garrel R, Hillaire-Buys D, et al
The following GLP-1 medications are FDA-approved for use in the United States: Liraglutide (Saxenda, Victoza) For type 2 diabetes and for long-term weight management in adults and some adolescents with obesity or overweight along with at least one weight-related condition
Further analyses revealed that cotadutide 300 g improved lipid profiles, liver enzyme levels (AST and ALT), and markers of liver fibrosis, including propeptide of type III collagen, and fibrosis-4 index, compared to placebo